Patent · US Active

VMAT inhibitory compounds

US9546151B2 · kind B2 · utility

0Cited by
3References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 31, 2015
Grant dateJan 17, 2017
Priority date
Expiry dateJul 31, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/519
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods of treatment using said compounds and pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.